Arintra
Intelligent medical assistant for reducing clinical overload on doctors.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | $21.0m | Series A | |
| Total Funding | 000k | ||
| EUR | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Arintra, a company at the forefront of healthcare technology, was founded with a vision to transform the way medical data is managed and utilized. Despite the lack of detailed public information about its founders and specific milestones, Arintra has made significant strides in the healthcare sector.
Arintra's core mission is to streamline healthcare processes by leveraging advanced technology to improve data accuracy and accessibility. This focus on innovation has positioned the company as a key player in the healthcare industry, offering solutions that enhance the efficiency of medical data management.
While specific details about major funding rounds or acquisitions remain elusive, Arintra's impact is evident in its growing presence and influence in healthcare technology. The company's journey reflects a commitment to improving healthcare outcomes through technological advancement, making it a noteworthy entity in the industry.